Factors influencing the development and implementation of new entomoceutical drugs in veterinary medicine

Recently, the use of insects in various directions has been increasing, and the field of veterinary pharmacology has not become an exception. Biologically active substances from insects have become the object of increasingly intensive research, due to their unique properties, wide variety and potential in humane as well as veterinary medicine. Scientific research is published annually, which examines a variety of options for the use of chemical compounds of insects for therapeutic and preventive purposes. But despite this, there are no mass-produced drugs recognized by the consumer. The phenomenon in which the number of scientific studies is not proportional to the products sold can be considered a natural process when unprofitable projects are eliminated, but, compared with other studies of sources of medicinal raw materials, an incomparable percentage of insect products "does not reach" mass sales. The identified causes slowing the development of entomoceutics can partially identify the shortcomings of modern humane and veterinary pharmacology and expand general knowledge about the subtle moment of transition from the initial idea to the products being sold by the example of insect medicines. Neural networks can make a significant contribution to the development of veterinary entomoceutics, allowing to accelerate the process of developing new drugs from insects, improve the selection of effective therapy for specific patients, taking into account genetic predispositions on which the activity of the body's enzymatic systems depends, as well as the presence or absence of idiosyncratic reactions in animals, and optimize ways to predict the activity of substances in a particular organism. With proper research, description of methods for the isolation and purification of active substances, centralized regulation, the use of neural networks and the necessary financing, entomoceutics is able to fill the market with high-quality veterinary pharmacological preparations, which, with less financial and time costs, will not yield pharmacokinetic and pharmacodynamic properties to medicinal substances obtained in a traditional longer-term way, which will allow in a short time to withdraw veterinary medicine pharmacology to a new qualitative level.